Last updated on September 2018

An Expanded Access Protocol for Apalutamide Treatment of Participants With Non-Metastatic Castration-Resistant Prostate Cancer


Brief description of study

The purpose of this study is to collect additional safety data until apalutamide is commercially available for participants with non-metastatic castrate-resistant prostate cancer (NM-CRPC).

Clinical Study Identifier: NCT03523338

Contact Investigators or Research Sites near you

Start Over

Study Contact

Hospital Central Sur de Alta Especialidad Pemex Picacho
Mexico, Mexico
1.55miles
  Connect »

Study Contact

Instituto Nacional de Cancerologia
Mexico, Mexico
3.55miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.